Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT04234841

Avr Thrombosis OutcoMe Study

Sponsor: East and North Hertfordshire NHS Trust

View on ClinicalTrials.gov

Summary

This study aims to utilise novel biomarkers assessing thrombosis and thrombolysis (through a blood test), to identify patients undergoing either surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) who are at risk of thrombosis, and relate this to clinical thrombotic and thromboembolic adverse events and subclinical valve thrombosis, and identify the timeframe of greatest risk for valve thrombosis.

Official title: Can Thrombosis and Fibrinolysis Markers in Patients Undergoing Aortic Valve Replacement Predict Outcome

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

750

Start Date

2020-02-01

Completion Date

2028-01

Last Updated

2020-01-21

Healthy Volunteers

No

Conditions

Interventions

DIAGNOSTIC_TEST

Blood test

Blood test

Locations (1)

East and North Hertfordshire NHS Trust

Stevenage, Hertforshire, United Kingdom